Fernando Martinez, MD

Scientific Advisory Board

Dr. Fernando Martinez joins APIE-Therapeutics as a member of the Scientific Advisory Board.  He is currently the Chief of the Division of Pulmonary and Critical Care Medicine at Weill Cornell Medicine in New York City.   His expertise covers (but not limited to) Interstitial Lung Disease, COPD (Chronic Obstructive Pulmonary Disease), Interstitial Pulmonary Fibrosis, Pulmonary Fibrosis and Respiratory Infections.  Prior to becoming Chief of the Division of Pulmonary and Critical Care Medicine at Weill Cornell Medicine, he was Professor of Internal Medicine and Associate Chief for Clinical Research in the Division of Pulmonary and Critical Care Medicine at the University of Michigan Health System, as well as Medical Director of its Pulmonary Diagnostic Services and Co-Medical Director of the Lung Transplantation Program.  Dr Fernando Martinez research interest includes COPD, interstitial lung disease, lung transplantation, and lung volume reduction.   He is a  member of the GOLD Science Committee and sit on a number of editorial boards, including the Journal of COPD and American Journal of Respiratory and Critical Care Medicine (including being the Deputy Editor). 

 

Dr Martinez holds an MD from University of Florida School of Medicine.

© 2020 by Apie Therapeutics. 

  • LinkedIn